Vimarsana
Biggest News Aggregation in the World

Page 21 - Protein Expression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Expression Today - Breaking & Trending Today

Small cell lung cancer subtypes respond differently to chemotherapeutics and targeted drugs - Vimarsana News

Small cell lung cancer subtypes respond differently to chemotherapeutics and targeted drugs

Small cell lung cancer (SCLC) is a malignant disease associated with a particularly high mortality rate. According to a new multicenter study led by MedUni Vienna and conducted in collaboration with researchers from the Czech Republic, Hungary, Slovenia, Sweden and the United States, SCLC can be divided into several subgroups in terms of clinical behavior.

Global Plant-based Biologics and Expression Systems Market - Vimarsana News

Global Plant-based Biologics and Expression Systems Market

Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Plant-based Biologics and Expression Systems Market Industry Trends and Global Forecasts, 2022-2035"...

Study investigates the production of a virosome-based COVID-19 vaccine candidate - Vimarsana News

Study investigates the production of a virosome-based COVID-19 vaccine candidate

In a new study, different signal peptides, baculovirus transfer vectors, cell lines, infection techniques, and formulation buffers were investigated with the purpose of building a scalable bioprocess to generate high-quality S protein for incorporation in a virosome-based COVID-19 vaccine candidate.

Role of cGAS-STING in SARS-CoV-2 infection - Vimarsana News

Role of cGAS-STING in SARS-CoV-2 infection

A new study analyzes the activation of cGAS and STING can induce a type I IFN response due to SARS-CoV-2 infection.

Developing and manufacturing custom recombinant antibodies for R&D - Vimarsana News

Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.